...
首页> 外文期刊>The Journal of Pharmacology and Experimental Therapeutics: Official Publication of the American Society for Pharmacology and Experimental Therapeutics >Coadministration of 5-hydroxytryptamine(1A) antagonist WAY-100635 prevents fluoxetine-induced desensitization of postsynaptic 5-hydroxytryptamine(1A) receptors in hypothalamus.
【24h】

Coadministration of 5-hydroxytryptamine(1A) antagonist WAY-100635 prevents fluoxetine-induced desensitization of postsynaptic 5-hydroxytryptamine(1A) receptors in hypothalamus.

机译:5-羟色胺(1A)拮抗剂WAY-100635的共同给药可防止氟西汀诱导下丘脑中突触后5-羟色胺(1A)受体的脱敏。

获取原文
获取原文并翻译 | 示例

摘要

Treatment with selective serotonin reuptake inhibitors induces a desensitization of hypothalamic postsynaptic 5-hydroxytryptamine (5-HT)(1A) receptors in humans and rats. This study investigated whether fluoxetine-induced desensitization is due to overactivation of postsynaptic 5-HT(1A) receptors; whether blockade of somatodendritic 5-HT(1A) autoreceptors accelerates this desensitization; and whether desensitization is associated with a reduction of Gz proteins, which couple to 5-HT(1A) receptors. WAY-100635 was tested at low doses (0.03-0.3 mg/kg), which antagonize somatodendritic 5-HT(1A) autoreceptors in the raphe nuclei, and at a higher dose (1 mg/kg), which completely blocks postsynaptic 5-HT(1A) receptors. Plasma levels of oxytocin and adrenal corticotrophic hormone (corticotropin) were measured as peripheral indicators of hypothalamic 5-HT(1A) receptor function. Daily injections of fluoxetine (10 mg/kg/day i.p.) for 2 days did not desensitize 5-HT(1A) receptors but three daily injections of fluoxetine produced a partial desensitization of the hormone responses to (+/-)-8-hydroxy-2-dipropylaminoetetralin (50 microg/kg s.c.). WAY-100635 (0.03-0.3 mg/kg) did not accelerate or potentiate the fluoxetine-induced desensitization of 5-HT(1A) receptors. However, WAY-100635 at a dose that completely blocks postsynaptic 5-HT(1A) receptors (1.0 mg/kg) completely prevented the fluoxetine-induced desensitization of 5-HT(1A) receptors. These data demonstrate that at least 3 days of fluoxetine exposure is required to produce a homologous desensitization of hypothalamic 5-HT(1A) receptors. Although previous studies indicate that injections of fluoxetine for 14 days produce a reduction of Gz protein levels in the hypothalamus, the levels of Gz proteins were not affected by either fluoxetine or WAY-100635. Alternative mechanisms mediating the initial stages of 5-HT(1A) receptor desensitization could involve post-translational modifications in the 5-HT(1A) receptor-Gz protein-signaling cascade.
机译:用选择性5-羟色胺再摄取抑制剂治疗可诱发人和大鼠下丘脑突触后5-羟色胺(5-HT)(1A)受体的脱敏。这项研究调查了氟西汀诱导的脱敏是否归因于突触后5-HT(1A)受体的过度激活。体树突状5-HT(1A)自体受体的阻滞是否加速了这种脱敏作用;以及脱敏是否与Gz蛋白的减少有关,后者与5-HT(1A)受体偶联。 WAY-100635在低剂量(0.03-0.3 mg / kg)下进行了测试,该剂量拮抗了缝核中的树突状5-HT(1A)自体受体,在更高剂量下(1 mg / kg)可以完全阻断突触后5- HT(1A)受体。血浆催产素和肾上腺皮质营养激素(促肾上腺皮质激素)的水平被测量为下丘脑5-HT(1A)受体功能的外围指标。每天注射氟西汀(10 mg / kg /天,腹腔注射)持续2天不会使5-HT(1A)受体脱敏,但是每天三次注射氟西汀会引起对(+/-)-8-羟基的激素反应部分脱敏-2-二丙基氨基四氢化萘(50 microg / kg sc)。 WAY-100635(0.03-0.3 mg / kg)不会加速或增强氟西汀诱导的5-HT(1A)受体脱敏。但是,WAY-100635的剂量可以完全阻断突触后的5-HT(1A)受体(1.0 mg / kg),完全可以阻止氟西汀诱导的5-HT(1A)受体脱敏。这些数据表明,至少需要3天的氟西汀暴露才能产生下丘脑5-HT(1A)受体的同源脱敏作用。尽管以前的研究表明,注射氟西汀14天会使下丘脑中的Gz蛋白水平降低,但Gz蛋白水平不受氟西汀或WAY-100635的影响。介导5-HT(1A)受体脱敏的初始阶段的替代机制可能涉及5-HT(1A)受体-Gz蛋白信号级联反应中的翻译后修饰。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号